AbbVie (ABBV) Inventory Average (2013 - 2026)
AbbVie (ABBV) posted quarterly Inventory Average of $5.0 billion for Q1 2026, up 14.85% year-over-year from $4.4 billion in Q1 2025, and up 1.12% quarter-over-quarter from $4.9 billion in Q4 2025.
AbbVie (ABBV) Inventory Average (2013 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Inventory Average for 14 consecutive years, with $5.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 14.85% year-over-year to $5.0 billion; the TTM figure through Mar 2026 stood at $5.0 billion (up 14.85% YoY), while the FY2025 annual figure was $4.6 billion, up 10.29% from the prior year.
- Inventory Average rose to $5.0 billion in Q1 2026 per ABBV's latest filing, from $4.9 billion in the prior quarter.
- Across five years, Inventory Average topped out at $5.0 billion in Q1 2026 and bottomed at $3.3 billion in Q3 2022.
- Historically, Inventory Average has averaged $4.1 billion across 5 years, with a median of $4.2 billion in 2024.
- Annual changes were most pronounced in 2022 — Inventory Average climbed 0.44% — and 2023, when it rose 22.35%.
- AbbVie's Inventory Average stood at $3.4 billion in 2022, then gained by 19.69% to $4.0 billion in 2023, then gained by 6.82% to $4.3 billion in 2024, then climbed by 14.58% to $4.9 billion in 2025, then rose by 1.12% to $5.0 billion in 2026.
- Business Quant data shows ABBV's Inventory Average at $5.0 billion in Q1 2026, $4.9 billion in Q4 2025, and $4.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.09 Bn |
| Mar 31, 2026 | 5.00 Bn |
| Dec 31, 2025 | 4.94 Bn |
| Sep 30, 2025 | 4.95 Bn |
| Jun 30, 2025 | 4.74 Bn |
| Mar 31, 2025 | 4.35 Bn |
| Dec 31, 2024 | 4.32 Bn |
| Sep 30, 2024 | 4.33 Bn |
| Jun 30, 2024 | 4.23 Bn |
| Mar 31, 2024 | 4.17 Bn |
| Dec 31, 2023 | 4.04 Bn |
| Sep 30, 2023 | 4.02 Bn |
| Jun 30, 2023 | 3.94 Bn |
| Mar 31, 2023 | 3.71 Bn |
| Dec 31, 2022 | 3.38 Bn |
| Sep 30, 2022 | 3.28 Bn |
| Jun 30, 2022 | 3.44 Bn |
| Mar 31, 2022 | 3.31 Bn |
| Dec 31, 2021 | 3.11 Bn |
| Sep 30, 2021 | 3.24 Bn |